Reelabs Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 2.23 Cr
as on 16-07-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.00 Cr
as on 16-07-2024
- Satisfied Charges ₹ 20.00 Cr
as on 16-07-2024
- Revenue 14.41%
(FY 2023)
- Profit 64.59%
(FY 2023)
- Ebitda 69.43%
(FY 2023)
- Net Worth 17.53%
(FY 2023)
- Total Assets 4.82%
(FY 2023)
About Reelabs
The Corporate was formerly known as Ree Labs Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.23 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹20.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Pophale, Rohit Kulkarni, and Abhijit Bopardikar serve as directors at the Company.
- CIN/LLPIN
U85100MH2009PTC190531
- Company No.
190531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Reelabs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Pophale  | Managing Director | 23-Feb-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Kulkarni | Director | 23-Feb-2009 | Current |
| Abhijit Bopardikar | Director | 23-Feb-2009 | Current |
Financial Performance and Corporate Structure Insights of Reelabs.
Reelabs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.41% increase. The company also saw a substantial improvement in profitability, with a 64.59% increase in profit. The company's net worth Soared by an impressive increase of 17.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reelabs?
In 2023, Reelabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Satiava Healthcare LlpActive 4 years 3 months
Rohit Kulkarni and Abhijit Bopardikar are mutual person
- R K Ubiquitous Strategic Advisors And Consultants LlpActive 1 year 30 days
Rohit Kulkarni is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Nov 2023 | ₹15.00 Cr | Open |
Others Creation Date: 15 Mar 2022 | ₹5.00 Cr | Satisfied |
Others Creation Date: 15 Mar 2022 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Reelabs?
Reelabs has a workforce of 45 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reelabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reelabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
